"While off-label use of drugs like remdesivir and ivermectin is being used, the FDA has only provided emergency use authorization for three monoclonal antibody treatments. Meanwhile, the approval of drugs from smaller companies like CytoDyn’s Leronlimab and Relief Theraputics’ aviptadil have not received an Emergency Use Authorization (EUA) or full FDA approval, despite their having far better safety profiles in clinical trials for other uses."

https://broadandliberty.com/2021/09/22/ben-ma...cine-bias/